Wakix

(pitolisant)

Wakix 4.45 MG Oral TabletWakix 17.8 MG Oral Tablet

NO BOXED WARNING

Dosage & administration

* Administer once daily in the morning upon wakening.
* The recommended dosage range is 17.8 mg to 35.6 mg daily. Titrate dosage as follows:
* Week 1: Initiate with 8.9 mg once daily
* Week 2: Increase dosage to 17.8 mg once daily
* Week 3: May increase to the maximum recommended dosage of 35.6 mg once daily

* Hepatic impairment :
* Moderate hepatic impairment: Initial dosage is 8.9 mg once daily. Titrate to a maximum dosage of 17.8 mg once daily after 14 days

* Renal impairment :
* Moderate and severe impairment: Initial dosage is 8.9 mg once daily. Titrate to maximum dosage of 17.8 mg once daily after 7 days
* End−stage renal disease (ESRD): Not recommended

* Poor Metabolizers of CYP2D6: Maximum recommended dosage is 17.8 mg once daily

drug label

Wakix prescribing information

Contact Medical Science Liaison Report Adverse Event

prior authorization

Wakix prior authorization resources

Most recent Wakix prior authorization forms

View By Payer

Verified: Nov 27, 2023Cigna - EDS Drugs Prior Authorization Form

Learn More

Benefits investigation

Wakix Prescription Referral Form

Learn More

financial assistance

Wakix financial assistance options

Co-pay savings program

commercial only

Enroll in Patient Savings Program

Wakix Prescription Referral Form

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form